Software Healthcare Sector

MediPharm Labs

Market Cap: CA$32.0m

Operates as a pharmaceutical company that produces and sells purified, pharmaceutical-like cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally.

More Life

Market Cap: CA$32.0m

A biotech company, focuses on advancing solutions to optimize human, animal, and plant health in Canada.

IXICO

Market Cap: UK£16.9m

Provides data analytics services to biopharmaceutical industry in the United States, the United Kingdom, the Netherlands, Denmark, Switzerland, Ireland, Europe, and internationally.

Resonance Health

Market Cap: AU$32.0m

A healthcare technology and services company, designs, develops, manufactures, and commercializes software-as-medical devices (SaMD) in the Asia Pacific, North America, Europe, the Middle East, and Africa.

Devonian Health Group

Market Cap: CA$31.6m

Operates as a clinical stage biopharmaceutical corporation with novel therapeutic approaches targeting unmet medical needs in Canada and Internationally.

ProBiotix Health

Market Cap: UK£16.6m

Develops probiotics to tackle cardiovascular disease and other lifestyle conditions in the United Kingdom, the United States, and internationally.

CleanSpace Holdings

Market Cap: AU$31.6m

Designs, manufactures, and sells respirators and related products and services for people working in industrial and healthcare environments in the United Kingdom, rest of Europe, the Asia Pacific, North America, and internationally.

Cerenome

Market Cap: US$22.5m

A clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer.

Cheelcare

Market Cap: CA$31.1m

Develops, manufactures, and distributes assistive mobility devices.

TempraMed Technologies

Market Cap: CA$31.1m

A medical device technology company, develops patent-protected technology designed to serve a broad range of medical and consumer products.

Celularity

Market Cap: US$22.4m

A cellular and regenerative medicine company, focuses on addressing aging-related disease using novel therapies.

Inspiration Healthcare Group

Market Cap: UK£16.4m

Designs, manufactures, and sells medical technology products worldwide.

Allarity Therapeutics

Market Cap: US$22.1m

A clinical-stage precision medicine pharmaceutical company, focuses on developing anti-cancer therapeutics for patients with unmet medical needs in Denmark and the United States.

Retractable Technologies

Market Cap: US$21.9m

Designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally.

ABVC BioPharma

Market Cap: US$21.8m

A clinical-stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States.

Biofrontera

Market Cap: US$21.7m

A biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

Concord Medical Services Holdings

Market Cap: US$21.6m

Through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China.

Cocrystal Pharma

Market Cap: US$21.4m

A biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States.

Nanollose

Market Cap: AU$29.9m

A biomaterials company, engages in the research and development, and promotion of microbial cellulose technologies in Australia.

Neuphoria Therapeutics

Market Cap: US$21.3m

A clinical stage biopharmaceutical company, discovers and develops novel allosteric ion channel modulators for the treatment of central nervous system disorders in Australia.

Noxopharm

Market Cap: AU$29.2m

A biotech company, engages in the discovering and developing treatments for cancer and inflammation, and mRNA vaccines in Australia.

Cosmos Health

Market Cap: US$20.8m

Manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, the United Arab Emirates, Albania, North Macedonia, and Cyprus.

Trajan Group Holdings

Market Cap: AU$29.0m

Develops, manufactures, and sells analytical and life science products and devices in Malaysia, Japan, Australia, New Zealand, the United States, Europe, the Middle East, Africa, and India.

dorsaVi

Market Cap: AU$29.0m

Engages in the development and sale of motion analysis technologies in Australia, Europe, and the United States.

Lifeward

Market Cap: US$20.6m

A medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, Germany, the Asia-Pacific, and internationally.

Pharmala Biotech Holdings

Market Cap: CA$28.4m

A biotechnology company, engages in the development, manufacture, and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community.

CareView Communications

Market Cap: US$20.5m

Provides video monitoring solutions in the United States.

EMV Capital

Market Cap: UK£14.8m

A venture capital firm specializing in seed, growth capital, early and mid stage investments.

Polyrizon

Market Cap: US$20.0m

A biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel.

Sharp Therapeutics

Market Cap: CA$27.4m

A preclinical-stage drug discovery company, develops therapeutics for genetic diseases.

Q/C Technologies

Market Cap: US$19.7m

Operates as a clinical-stage pharmaceutical company.

Cambridge Cognition Holdings

Market Cap: UK£14.4m

Develops and markets digital solutions for the assessment of brain health in the United States, United Kingdom, the European Union, and internationally.

NeuroOne Medical Technologies

Market Cap: US$19.7m

A medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States.

Proteomics International Laboratories

Market Cap: AU$27.3m

Operates as a medical technology company with a focus on the area of proteomics in Australia, New Zealand, the United States, Europe, India, and Southeast Asia.

Biomind Labs

Market Cap: US$19.4m

A biotech research and development company, focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various psychiatric and neurological conditions.

CelLBxHealth

Market Cap: UK£14.2m

A medical diagnostic company, develops cancer diagnostics products in the United Kingdom, Europe, North America, and internationally.